NIK-dependent RelB activation defines a unique signaling pathway for the development of Vα14i NKT cells

Journal of Experimental Medicine

Volumn 197, Issue 12, 2003, Pages 1623-1633

  Elewaut, Dirk ^a,f   Shaikh, Raziya B ^a,b   Hammond, Kirsten J L ^a   De Winter, Hilde ^a   Leishman, Andrew J ^c   Sidobre, Stephane ^a   Turovskaya, Olga ^a   Prigozy, Theodore I ^d   Ma, Lisa ^a   Banks, Theresa A ^a   Lo, David ^e   Ware, Carl F ^a,b   Cheroutre, Hilde ^a   Kronenberg, Mitchell ^a,b  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c PPL Therapeutics   (United Kingdom)

^d Tampa Bay Research Institute   (United States)

^e Digital Gene Technologies Inc   (United States)

^f GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

CD1; Lipid antigens; Lymphocyte development; NF B; T lymphocytes

Indexed keywords

CD11 ANTIGEN; CD1D ANTIGEN; CELL SURFACE RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NUCLEAR FACTOR KAPPA BETA INDUCING KINASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR REL; TRANSCRIPTION FACTOR RELB; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN PRESENTING CELL; ARTICLE; CELL ACTIVATION; CELL MATURATION; CELL TYPE; CONTROLLED STUDY; GENE MUTATION; HEMATOPOIETIC CELL; HETEROZYGOSITY; LYMPHOID ORGAN; MOUSE; MOUSE STRAIN; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOSENSITIVITY; SIGNAL TRANSDUCTION; STROMA CELL; T LYMPHOCYTE SUBPOPULATION; THYMUS;

ANIMALS; ANTIGENS, CD1; ANTIGENS, CD44; BETA 2-MICROGLOBULIN; CELL DIFFERENTIATION; CELLS, CULTURED; CHIMERA; FIBROBLASTS; KILLER CELLS, NATURAL; LYMPHOTOXIN BETA RECEPTOR; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NF-KAPPA B; PEYER'S PATCHES; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS; THYMUS GLAND; TRANSCRIPTION FACTOR RELB; TRANSCRIPTION FACTORS;

EID: 0038544169     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20030141     Document Type: Article

References (60)

1. Karin, M., and M. Delhase. 2000. The I kappa B kinase (IKK) and NF-kappa B: key elements of proinflammatory signalling. Semin. Immunol. 12:85-98.
2. Ghosh, S., M.J. May, and E.B. Kopp. 1998. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16:225-260.
3. Beg, A.A., W.C. Sha, R.T. Bronson, S. Ghosh, and D. Baltimore. 1995. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature. 376:167-170.
4. Burkly, L., C. Hession, L. Ogata, C. Reilly, L.A. Marconi, D. Olson, R. Tizard, R. Cate, and D. Lo. 1995. Expression of relB is required for the development of thymic medulla and dendritic cells. Nature. 373:531-536.
5. Wu, L., A. D'Amico, K.D. Winkel, M. Suter, D. Lo, and K. Shortman. 1998. RelB is essential for the development of myeloid-related CD8alpha-dendritic cells but not of lymphoid-related CD8alpha+ dendritic cells. Immunity. 9:839-847.
6. Lo, D., H. Quill, L. Burkly, B. Scott, R.D. Palmiter, and R.L. Brinster. 1992. A recessive defect in lymphocyte or granulocyte function caused by an integrated transgene. Am. J. Pathol. 141:1237-1246.
7. Weih, D.S., Z.B. Yihmaz, and F. Weih. 2001. Essential role of RelB in germinal center and marginal zone formation and proper expression of homing chemokines. J. Immunol. 167:1909-1919.
8. Weih, F., D. Carrasco, S.K. Durham, D.S. Barton, C.A. Rizzo, R.P. Ryseck, S.A. Lira, and R. Bravo. 1995. Multi-organ inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-kappa B/Rel family. Cell. 80:331-340.
9. Barton, D., H. HogenEsch, and F. Weih. 2000. Mice lacking the transcription factor RelB develop T cell-dependent skin lesions similar to human atopic dermatitis. Eur. J. Immunol. 30:2323-2332.
10. DeKoning, J., L. DiMolfetto, C. Reilly, Q. Wei, W.L. Havran, and D. Lo. 1997. Thymic cortical epithelium is sufficient for the development of mature T cells in relB-deficient mice. J. Immunol. 158:2558-2566.
11. Lantz, O., and A. Bendelac. 1994. An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4-8-T cells in mice and humans. J. Exp. Med. 180:1097-1106.
12. Arase, H., N. Arase, K. Ogasawara, R.A. Good, and K. Onoe. 1992. An NK1.1+ CD4+8-single-positive thymocyte subpopulation that expresses a highly skewed T-cell antigen receptor V beta family. Proc. Natl. Acad. Sci. USA. 89:6506-6510.
13. Ohteki, T., and H.R. MacDonald. 1996. Stringent V beta requirement for the development of NK1.1+ T cell receptor-alpha/beta+ cells in mouse liver. J. Exp. Med. 183:1277-1282.
14. Eberl, G., R. Lees, S.T. Smiley, M. Taniguchi, M.J. Grusby, and H.R. MacDonald. 1999. Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells. J. Immunol. 162:6410-6419.
15. Burdin, N., L. Brossay, Y. Koezuka, S.T. Smiley, M.J. Grusby, M. Gui, M. Taniguchi, K. Hayakawa, and M. Kronenberg. 1998. Selective ability of mouse CD1 to present glycolipids: alpha-galactosylceramide specifically stimulates V alpha 14+ NK T lymphocytes. J. Immunol. 161:3271-3281.
16. Kawano, T., J. Cui, Y. Koezuka, I. Toura, Y. Kaneko, K. Motoki, H. Ueno, R. Nakagawa, H. Sato, E. Kondo, H. Koseki, and M. Taniguchi. 1997. CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science. 278:1626-1629.
17. Kronenberg, M., and L. Gapin. 2002. The unconventional lifestyle of NKT cells. Nat. Rev. Immunol. 2:557-568.
18. Matsuda, J.L., O.V. Naidenko, L. Gapin, T. Nakayama, M. Taniguchi, C.R. Wang, Y. Koezuka, and M. Kronenberg. 2000. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J. Exp. Med. 192:741-754.
19. Benlagha, K., A. Weiss, A. Beavis, L. Teyton, and A. Bendelac. 2000. In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers. J. Exp. Med. 191:1895-1903.
20. Pellicci, D.G., K.J. Hammond, A.P. Uldrich, A.G. Baxter, M.J. Smyth, and D.I. Godfrey. 2002. A natural killer T (NKT) cell developmental pathway involving a thymus-dependent NK1.1(-)CD4(+) CD1d-dependent precursor stage. J. Exp. Med. 195:835-844.
21. Gapin, L., J.L. Matsuda, C.D. Surh, and M. Kronenberg. 2001. NKT cells derive from double-positive thymocytes that are positively selected by CD1d. Nat. Immunol. 2:971-978.
22. Miyawaki, S., Y. Nakamura, H. Suzuka, M. Koba, R. Yasumizu, S. Ikehara, and Y. Shibata. 1994. A new mutation, aly, that induces a generalized lack of lymph nodes accompanied by immnunodeficiency in mice. Eur. J. Immunol. 24:429-434.
23. Burdin, N., L. Brossay, and M. Kronenberg. 1999. Immunization with alpha-galactosylceramide polarizes CD1-reactive NK T cells towards Th2 cytokine synthesis. Eur. J. Immunol. 29:2014-2025.
24. Force, W.R., B.N. Walter, C. Hession, R. Tizard, C.A. Kozak, J.L. Browning, and C.F. Ware. 1995. Mouse lymphotoxin-beta receptor. Molecular genetics, ligand binding, and expression. J. Immunol. 155:5280-5288.
25. Watanabe, H., K. Ohtsuka, M. Kimura, Y. Ikarashi, K. Ohmori, A. Kusumi, T. Ohteki, S. Seki, and T. Abo. 1992. Details of an isolation method for hepatic lymphocytes in mice. J. Immunol. Methods. 146:145-154.
26. Feng, L., Y. Xia, J.I. Kreisberg, and C.B. Wilson. 1994. Interleukin-1 alpha stimulates KC synthesis in rat mesangial cells: glucocorticoids inhibit KC induction by IL-1. Am. J. Physiol. 26:F713-F22.
27. Xia, Y., M.E. Pauza, L. Feng, and D. Lo. 1997. RelB regulation of chemokine expression modulates local inflammation. Am. J. Pathol. 151:375-387.
28. Matsumoto, M., K. Iwamasa, P.D. Rennert, T. Yamada, R. Suzuki, A. Matsushima, M. Okabe, S. Fujita, and M. Yokoyama. 1999. Involvement of distinct cellular compartments in the abnormal lymphoid organogenesis in lymphotoxin-alpha-deficient mice and alymphoplasia (aly) mice defined by the chimeric analysis. J. Immunol. 163:1584-1591.
29. DiDonato, J.A., F. Mercurio, and M. Karin. 1995. Phosphorylation of I kappa B alpha precedes but is not sufficient for its dissociation from NF-kappa B. Mol. Cell. Biol. 15:1302-1311.
30. Elewaut, D., J.A. DiDonato, J.M. Kim, F. Truong, L. Eckmann, and M.F. Kagnoff. 1999. NF-kappa B is a central regulator of the intestinal epithelial cell innate immune response induced by infection with enteroinvasive bacteria. J. Immunol. 163:1457-1466.
31. Bix, M., M. Coles, and D. Raulet. 1993. Positive selection of V beta 8+ CD4-8-thymocytes by class I molecules expressed by hematopoietic cells. J. Exp. Med. 178:901-908.
32. Bendelac, A., N. Killeen, D.R. Littman, and R.H. Schwartz. 1994. A subset of CD4+ thymocytes selected by MHC class I molecules. Science 263:1774-1778.
33. Coles, M.C., and D.H. Raulet. 1994. Class I dependence of the development of CD4+ CD8-NK1.1+ thymocytes. J. Exp. Med. 180:395-399.
34. Bendelac, A. 1995. Positive selection of mouse NK1+ T cells by CD1-expressing cortical thymocytes. J. Exp. Med. 182:2091-2096.
35. Coles, M.C., and D.H. Raulet. 2000. NK1.1+ T cells in the liver arise in the thymus and are selected by interactions with class I molecules on CD4+CD8+ cells. J. Immunol. 164:2412-2418.
36. Shinkura, R., K. Kitada, F. Matsuda, K. Tashiro, K. Ikuta, M. Suzuki, K. Kogishi, T. Serikawa, and T. Honjo. 1999. Alymphoplasia is caused by a point mutation in the mouse gene encoding Nf-kappa b-inducing kinase. Nat. Genet. 22:74-77.
37. Nakagawa, K., K. Iwabuchi, K. Ogasawara, M. Ato, M. Kajiwara, H. Nishihori, C. Iwabuchi, H. Ishikura, R.A. Good, and K. Onoe. 1997. Generation of NK1.1+ T cell antigen receptor alpha/beta+ thymocytes associated with intact thymic structure. Proc. Natl. Acad. Sci. USA. 94:2472-2477.
38. Konishi, J., K. Iwabuchi, C. Iwabuchi, M. Ato, J.I. Nagata, K. Onoe, K.I. Nakagawa, M. Kasai, K. Ogasawara, and K. Kawakami. 2000. Thymic epithelial cells responsible for impaired generation of NK-T thymocytes in Alymphoplasia mutant mice. Cell. Immunol. 206:26-35.
39. Yin, L., L. Wu, H. Wesche, C.D. Arthur, J.M. White, D.V. Goeddel, and R.D. Schreiber. 2001. Defective lymphotoxin-beta receptor-induced NF-kappaB transcriptional activity in NIK-deficient mice. Science. 291:2162-2165.
40. Tilloy, F., J.P. Di Santo, A. Bendelac, and O. Lantz. 1999. Thymic dependence of invariant V alpha 14+ natural killer-T cell development. Eur. J. Immunol. 29:3313-3318.
41. Shimamura, M., T. Ohteki, P. Launois, A.M. Garcia, and H.R. MacDonald. 1997. Thymus-independent generation of NK1+ T cells in vitro from fetal liver precursors. J. Immunol. 158:3682-3689.
42. Shimamura, M., Y.Y. Huang, Y. Suda, S. Kusumoto, K. Sato, M.J. Grusby, H. Sato, T. Nakayama, and M. Taniguchi. 1999. Positive selection of NKT cells by CD1(+), CDllc(+) non-lymphoid cells residing in the extrathymic organs. Eur. J. Immunol. 29:3962-3970.
43. Bendelac, A., and R.H. Schwartz. 1991. CD4+ and CD8+ T cells acquire specific lymphokine secretion potentials during thymic maturation. Nature. 3539:68-71.
44. Bendelac, A., P. Matzinger, K.A. Seder, W.E. Paul, and K.H. Schwartz. 1992. Activation events during thymic selection. J. Exp. Med. 175:731-742.
45. Matsuda, J.L., L. Gapin, S. Sidobre, W.C. Kieper, J.T. Tan, R. Ceredig, C.D. Surh, and M. Kronenberg. 2002. Homeostasis of V alpha 14i NKT cells. Nat. Immunol. 3:966-974.
46. Benlagha, K., T. Kyin, A. Beavis, L. Teyton, and A. Bendelac. 2002. A thymic precursor to the NK T cell lineage. Science. 296:553-555.
47. Lembecher, T., U. Muller, and T. Wirth. 1993. Distinct NF-kappa B/Rel transcription factors are responsible for tissue-specific and inducible gene activation. Nature. 365:767-770.
48. Lembecher, T., B. Kistler, and T. Wirth. 1994. Two distinct mechanisms contribute to the constitutive activation of RelB in lymphoid cells. EMBO J. 13:4060-4069.
49. Weih, F., D. Carrasco, and R. Bravo. 1994. Constitutive and inducible Rel/NF-kappa B activities in mouse thymus and spleen. Oncogene. 9:3289-3297.
50. Carrasco, D., R.P. Ryseck, and R. Bravo. 1993. Expression of relB transcripts during lymphoid organ development: specific expression in dendritic antigen-presenting cells. Development. 118:1221-1231.
51. Neumann, M., G. Wohlleben, S. Chuvpilo, B. Kistler, T. Wirth, E. Serfling, and A. Schimpl. 1996. CD40, but not lipopolysaccharide and anti-IgM stimulation of primary B lymphocytes, leads to a persistent nuclear accumulation of RelB. J. Immunol. 157:4862-4869.
52. Lin, S.C., H.H. Wortis, and J. Stavnezer. 1998. The ability of CD40L, but not lipopolysaccharide, to initiate immunoglobulin switching to immunoglobulin G1 is explained by differential induction of NF-kappaB/Rel proteins. Mol. Cell. Biol. 18:5523-5532.
53. Dejardin, E., V. Deregowski, R. Greimers, Z. Cai, S. Chouaib, M.P. Merville, and V. Bours. 1998. Regulation of major histocompatibility complex class I expression by NF-kappaB-related proteins in breast cancer cells. Oncogene. 16:3299-3307.
54. Dejardin, E., N.M. Droin, M. Delhase, E. Haas, Y. Cao, C. Makris, Z.W. Li, M. Karin, C.F. Ware, and D.R. Green. 2002. The Lymphotoxin-beta Receptor Induces Different Patterns of Gene Expression via Two NF-kappaB Pathways. Immunity. 17:525-530.
55. Dobrzanski, P., R.P. Ryseck, and R. Bravo. 1995. Specific inhibition of RelB/p52 transcriptional activity by the C-terminal domain of p100. Oncogene. 10:1003-1007.
56. Caamano, J.H., C.A. Rizzo, S.K. Durham, D.S. Barton, C. Raventos-Suarez, C.M. Snapper, and R. Bravo. 1998. Nuclear factor (NF)-kappa B2 (p100/p52) is required for normal splenic microarchitecture and B cell-mediated immune responses. J. Exp. Med. 187:185-196.
57. Sha, W.C., H.C. Liou, E.I. Tuomanen, and D. Baltimore. 1995. Targeted disruption of the p50 subunit of NF-kappa B leads to multifocal defects in immune responses. Cell. 80:321-330.
58. Xiao, G., E.W. Harhaj, and S.C. Sun. 2001. NF-kappaB-inducing kinase regulates the processing of NF-kappaB2 p100. Mol. Cell. 7:401-409.
59. Weih, F., S.K. Durham, D.S. Barton, W.C. Sha, D. Baltimore, and R. Bravo. 1997. p50-NF-kappaB complexes partially compensate for the absence of RelB: severely increased pathology in p50(-/-)relB(-/-) double-knockout mice. J. Exp. Med. 185:1359-1370.
60. Xia, Y., S. Chen, Y. Wang, N. Mackman, G. Ku, D. Lo, and L. Feng. 1999. RelB modulation of IkappaBalpha stability as a mechanism of transcription suppression of interleukin-lalpha (IL-lalpha), IL-1beta, and tumor necrosis factor alpha in fibroblasts. Mol. Cell. Biol. 19:7688-7696.